Articles by Disease (Mesothelioma)

Antisense Strategies

Journal: Current Molecular Medicine
Volume: 4
Page: 465-487
Author(s): Stanley T. Crooke

Small Molecule Toxins Targeting Tumor Receptors

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2311-2334
Author(s): Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda

Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1
Page: 291-295
Author(s): John W. Ho, Jing Zheng Song and Qian Li

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Journal: Current Cancer Drug Targets
Volume: 4
Page: 267-283
Author(s): X. Chen, S. Wang, N. Wu and C. S. Yang

Drug Delivery Systems for Brain Tumor Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1341-1353
Author(s): Jarkko Rautioa and Prashant J. Chikhale

The Pharmacological Treatment of Cachexia

Journal: Current Drug Targets
Volume: 5
Page: 265-277
Author(s): Josep M. Argiles, Vanessa Almendro, Sílvia Busquets and Francisco J. Lopez-Soriano

Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4
Page: 123-138
Author(s): Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni

Angiogenesis: A Target for Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 11-26
Author(s): Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello

Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 334-342
Author(s): Patrizia Marini and Claus Belka

Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations

Journal: Current Topics in Medicinal Chemistry
Volume: 3
Page: 1103-1114
Author(s): Arthur G. Taveras, Paul Kirschmeier and Charles M. Baum